Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d27415c4dbafeff331caf3aad9a8519 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
2002-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c0a480ea3203c63797e28173e170f17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d261a0b52f4f64e41fdcad3c5ba0852 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c742a0b90295afdef536af080afd01cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa0022d72afb7b7a8006ac95a4ff321a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2c73935aa9f74ac792a5dfc16af006d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39075f0c098e30d93fed4f0d2acb79c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b2b8ec27c257c8457f615c0bc6e2bca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_939f3ec148945902a4c3866996d56659 |
publicationDate |
2004-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20040041713-A |
titleOfInvention |
Inhibitor from Adhesion between Candida and Its Host Cell Comprising Transglutaminase as Active Ingredient |
abstract |
The present invention relates to a binding inhibitor between the microorganism of the genus Candida and its host cell, and more particularly to a binding inhibitor including a transglutaminase that inhibits the binding between the microorganism of the genus Candida and its host cell. The present invention provides an antifungal pharmaceutical composition comprising a binding inhibitor between a microorganism of the genus Candida comprising a transglutaminase and its host cell, and a transglutaminase. The binding inhibitor of the present invention successfully inhibits the binding between the microorganism of the genus Candida and the host cell, and the antifungal pharmaceutical composition of the present invention exhibits the antifungal effect against Candida disease by directly inhibiting the binding of the microorganism of the genus Candida and the host cell. . |
priorityDate |
2002-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |